Ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) inhibits insulin signaling and action. Understanding the mechanisms underlying ENPP1 expression may help unravel molecular mechanisms of insulin resistance. Recent data suggest a role of ENPP1-3′untraslated region (UTR), in controlling ENPP1 expression. We sought to identify trans-acting ENPP1-3′UTR binding proteins, and investigate their role on insulin signaling. By RNA pull-down, 49 proteins bound to ENPP1-3′UTR RNA were identified by mass spectrometry (MS). Among these, in silico analysis of genome wide association studies and expression profile datasets pointed to N-acetylgalactosaminyltransferase 2 gene (GALNT2) for subsequent investigations. Gene expression levels were evaluated by RT-PCR. Protein expression levels, IRS-1 and Akt phosphorylation were evaluated by Western blot. Insulin receptor (IR) autophosphorylation was evaluated by ELISA. GALNT2 down-regulation increased while GALNT2 over-expression reduced ENPP1 expression levels. In addition, GALNT2 down-regulation reduced insulin stimulation of IR, IRS-1 and Akt phosphorylation and insulin inhibition of phosphoenolpyruvate carboxykinase (PEPCK) expression, a key neoglucogenetic enzyme. Our data point to GALNT2 as a novel factor involved in the modulation of ENPP1 expression as well as insulin signaling and action in human liver HepG2 cells.
Introduction
Insulin resistance plays a major role in the pathogenesis of type 2 diabetes, pro-atherogenic dyslipidemia and cardiovascular disease, thus imposing a tremendous burden to morbidity and mortality in developed countries [1] .
The molecular mechanisms underlying insulin resistance are mostly unraveled [2] . Among several molecules involved in this process, the class II transmembrane glycoprotein ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) was identified as a putative candidate. ENPP1 binds to [3] and inhibits the insulin receptor (IR) and subsequent downstream insulin signaling and action in both cultured cells [4] [5] [6] [7] [8] [9] [10] and animal models [9, 11, 12] . In addition, ENPP1 is over-expressed in several tissues of insulin-resistant subjects [13] [14] [15] [16] [17] . Finally, in vitro and in vivo studies on a gain of function amino acid substitution (i.e. K121Q polymorphism; rs1805101) provided further support to the notion that ENPP1 affects insulin action [7, 10, [18] [19] [20] [21] [22] . Thus, unraveling the mechanisms involved in the modulation of ENPP1 expression might help developing strategies aimed at counteracting and possibly reversing some forms of insulin resistance.
Recent data indicated that the 3′untranslated region (UTR) of ENPP1 mRNA plays a role in controlling ENPP1 expression, suggesting the existence of trans-acting proteins that affect ENPP1 mRNA stability [23, 24] . The aim of this study was to identify specific ENPP1-3′ UTR binding proteins by means of RNA pull-down experiments and to investigate their potential role on affecting ENPP1 expression and modulating insulin signaling and action in human liver cells, the utmost target of insulin action on glucose homeostasis.
Materials and methods

RNA preparation
The most conserved region (i.e. nucleotide (nt) 2750 to nt 3176 of the ENPP1 cDNA) of ENPP1-3′UTR (either wild type or polymorphic-"P" [25] ) was obtained as previously described [24] and then used as template. The antisense sequence of the same region was used as control RNA.
RNA pull-down
In order to identify those proteins which specifically bind the ENPP1-3′UTR, the RNA pull-down with adipic acid dehydrazide bead method was used. Briefly, 15 μg of ENPP1-3′UTR, "P" ENPP1-3′UTR or control RNA, obtained as previously described [24] , was placed in a 400 μl reaction mixture containing 100 mmol/l NaOAc, pH 5.2, and 5 mmol/l sodium m-periodate (Sigma-Aldrich, St. Louis, MO), incubated for 1 h in the dark at room temperature, ethanol precipitated, and resuspended in 100 μl of 100 mmol/l NaOAc, pH 5.2. Then 300 μl of adipic acid dehydrazide agarose beads 50% slurry (Sigma-Aldrich, St. Louis, MO) equilibrated in 100 mmol/l NaOAc, pH 5.2, was added to this mixture and incubated for 12 h at 4°C on a rotator. The RNA that covalently immobilized onto agarose beads was pelleted, washed twice with 1 ml of 2 mol/l NaCl, equilibrated in washing buffer (5 mmol/l HEPES, pH 7.9, 1 mmol/l MgCl 2 , 0.8 mmol/l magnesium acetate) and, finally, incubated with 3 mg of cellular protein extract for 30 min at room temperature in 0.6 ml final volume. Heparin was also added to a final concentration of 7 μg/μl. After further washing (i.e. four times in 1.5 ml of washing buffer), proteins retained by RNA sequences were eluted in SDS sample buffer and fractionated by a 12.5% SDS-PAGE. Gels were stained with colloidal blue staining kit (Invitrogen Life Technologies, Carlsbad, CA) [26, 27] .
Identification and characterizations of ENPP1-3′UTR binding proteins
Protein bands were excised from the destained gel, reduced, alkylated and digested with trypsin [28] . Peptide mixtures were extracted from the gel and analyzed by nano-chromatography tandem MS (nanoLC-MS/MS) on a CHIP MS Ion Trap XCT Ultra equipped with a capillary 1100 HPLC system and a chip cube (Agilent Technologies, Palo Alto, CA). Peptide analysis was performed using data-dependent acquisition of one MS scan (mass range from 400 to 2000 m/z) followed by MS/MS scans of the three most abundant ions in each MS scan. Raw data from nanoLC-MS/MS analyses were employed to query a non-redundant protein database using in house MASCOT software (Matrix Science, Boston, MA). Proteins identified in both the control and the sample lane were discarded, whereas those proteins solely identified in the sample and absent in the control were selected as putative ENPP1-3′UTR interactors.
In silico analysis
In order to prioritize proteins that were specifically bound to ENPP1-3′ UTR and identified by mass spectrometry analysis, we interrogated and cross-checked genome wide association studies (GWAS) and expression profile datasets. Only proteins coded by genes that satisfied the following criteria were selected for further analyses: 
RNA extraction, cDNA synthesis, and gene expression analysis
Total RNA was isolated from cells using RNeasy Mini kit (Qiagen S.r.l., Milan, Italy). cDNA was generated by reverse transcription with iScript™ Reverse Transcription (Biorad, Hercules, CA) according to the manufacturer's instructions and used as template in the subsequent analyses. Gene Expression Assay on Demand Kit Reagents (Applera Life Technologies, Carlsbad, CA) or PrimeTime Std qPCR Assay (IDT, San Jose, CA) were used to quantify relative gene expression levels of ENPP1, PEPCK (phosphoenolpyruvate carboxykinase) and GAPDH (glyceraldehyde 3-phosphate dehydrogenase) on ABI-PRISM 7500 (Applera Life Technologies, Carlsbad, CA). Expression levels of ENPP1 and PEPCK were calculated by using the comparative ΔCT method. Briefly, the amount of ENPP1 and PEPCK were normalized to GAPDH as endogenous reference (2
−ΔCT
) in experiments run in triplicate and expressed as percentage of control cells of the first of several experiments.
Antibodies
Antibody directed against GALNT2 was obtained from Abcam (Cambridge, UK). Anti-ENPP1 anti-GAPDH and anti-IR β-subunit antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-Phospho-IRS-1 Tyr
895
, anti-IRS-1, anti-Phospho-Akt Ser 473 and
anti-Akt, antibodies were purchased from Cell signaling (Boston, MA).
Western blot analysis
Cell lysates were separated by SDS-PAGE and transferred to nitrocellulose membrane (Amersham Pharmacia Biotech, Piscataway, NJ). After blotting with specific antibodies described above, immunocomplexes were detected with the Super Signal West Pico (Thermo Fisher Scientific Pierce, Rockford, IL 
IR β-subunit autophosphorylation
After 18 h starvation, both GALNT2 silenced and GALNT2 transfected as well as their respective control HepG2 cells were stimulated with 100 nmol/l insulin for 5 min and lysed. IR β-subunit autophosphorylation was analyzed by using CST's PathScan Phospho-Insulin Receptor β (Tyr1150/1151) solid phase sandwich enzyme-linked immunosorbent assay (ELISA) Kit according to manufacturer's instruction (Cell signaling, Boston, MA). Briefly, equal amount of protein was incubated with a coated anti-Insulin Receptor β mouse antibody in order to capture both phospho-and nonphospho-insulin receptor proteins. Following extensive washing, anti-phospho Insulin Receptor β (Tyr1150/1151) rabbit antibody is added to detect the captured phospho-insulin receptor protein. Anti-rabbit IgG, HRP-linked antibody is then used to recognize the bound detection antibody. OD values were used as a measure of IR β-subunit autophosphorylation. Data are means ± SD.
IRS-1-Tyr 895 and Akt-Ser 473 phosphorylation
After 18 h starvation, GALNT2 silenced or not silenced HepG2 cells were stimulated with 100 nmol/l insulin for 5 min and lysed; then, equal amount of proteins was analyzed by Western blot and probed with anti-Phospho-IRS-1 Tyr 895 , anti-Phospho-Akt Ser 473 , anti IRS-1 or anti-Akt. IRS-1 and Akt phosphorylation levels were normalized against IRS-1 or Akt content and expressed as described above.
PEPCK mRNA expression levels
Insulin action on glucose metabolism was assessed by studying mRNA level of the gluconeogenetic enzyme PEPCK in HepG2 cells. After 18 h starvation, silenced or not silenced HepG2 cells were stimulated with 100 nmol/l insulin for 10 h. Total RNA extraction and cDNA synthesis and PEPCK mRNA level measurement were performed as previously reported [10] and calculated as described above.
Statistical analyses
Differences between the mean values were evaluated by Student's t test. Data are presented as means ± SD. SPSS 13 software package was used for all analyses.
Results
Identification and characterization of GALNT2 as an ENPP1-3′UTR binding proteins
Proteins that specifically bind the ENPP1-3′UTR were identified by a functional proteomic approach using affinity capture and tandem MS. Fig. 1 shows the corresponding gel stained with colloidal blue Coomassie. The entire sample and control lanes of the gel were cut in slices and proteins occurring in each slice were identified by tandem-MS. Common proteins identified in both the sample and the control gel slices were eliminated, thus greatly decreasing the number of false positives. A total of forty-nine putative candidate proteins were identified (Supplementary Table 1) .
A screening procedure was applied to the list of identified proteins to select the most promising 3′UTR interactors by interrogating GWAS and expression profile datasets using the selection criteria described in Materials and methods. Among the forty-nine putative protein interactors, ten matched the inclusion criteria at the GWAS dataset, whereas only two proteins were selected when using the expression profile datasets. When data from the two screening procedures were cross-checked, only GALNT2 matched inclusion criteria at both datasets and was, then, selected for subsequent investigation. The GALNT2 gene codes for an UDP-N-acetyl-alpha-D-galactosamine polypeptide N-acetylgalactosaminyltransferase (O-GalNAc) which contributes to the initiation of mucin-type O-linked glycosylation [29] .
Confirmation of GALNT2-ENPP1-3′UTR interaction
The interaction of GALNT2 with ENPP1-3′UTR RNA was confirmed by an additional RNA pull-down assay from HEK293 total protein extract followed by Western-blot analysis (Fig. 2) . By using anti-GALNT2 specific antibody, a clear band was detected in RNA pulled-down human HEK293 cells (Fig. 2 panel A (Fig. 2 panel B) . Such binding was not influenced by the polymorphic "P" 3′UTR haplotype ( Supplementary  Fig. 1 ), reported to affect ENPP1 mRNA expression [25] .
Role of GALNT2 downregulation on ENPP1 expression and on insulin signaling and action
Exposure of HepG2 cells to GALNT2 siRNA for both 48 and 96 h almost abolished GALNT2 expression as compared to scrambled siRNA transfected cells (Fig. 3 , panel A: lanes 2 vs. 1, n = 3 and lanes 4 vs. 3, n = 5, respectively). As compared to scrambled siRNA transfected cells, in GALNT2 downregulated cells (Fig. 3, panel B) , ENPP1 expression tended to be increased at 48 h (i.e. 43% increase, p = 0.05-0.1), and was significantly increased at 96 h (116% increase, p b 0.05). Coherently, although to a lesser extent, also ENPP1 protein level was increased at 96 h in GALNT2 downregulated as compared to control cells (27% increase, p b 0.01, Fig. 3, panel C) .
Given the well established inhibitory role of ENPP1 on insulin signaling and action [10] , we tested the effect of GALNT2 downregulation on such pathways. After GALNT2 downregulation, insulin-induced IR Fig. 1 . SDS-PAGE of RNA protein pulled-down. HEK293 total protein extract was incubated with either agarose beads alone (lane 1) or ENPP1-3′UTR RNA (lane 2) or control RNA (lane 3) covalently linked to agarose beads. The complex were eluted with SDS sample buffer, loaded on 12.5% SDS-PAGE, separated by electrophoresis and stained with colloidal blue staining kit. Entire lanes observed in the gel were cut in slices and submitted to the identification procedure as described in Materials and methods.
β-subunit autophosphorylation (Fig. 4 panel B) was significantly reduced as compared to insulin-stimulated scrambled siRNA cells (23% reduction, p b 0.05). IR protein content was superimposable across all different experimental conditions (Fig. 4 panel A) . In GALNT2 siRNA cells also IRS-1 Tyr 895 (Fig. 5, panel A) and Akt-Ser 473 (Fig. 5, panel B) phosphorylations were significantly reduced as compared to what observed in insulin-stimulated scrambled siRNA cells (25% reduction p b 0.01 and 57% reduction p b 0.05 respectively). Insulin significantly suppressed gluconeogenetic enzyme PEPCK mRNA levels in scrambled siRNA cells (54% reduction, p b 0.01). This effect was partially lost in GALNT2 siRNA HepG2 cells in which only a 33% reduction of PEPCK mRNA levels was found (p = not significant vs. non insulin stimulated cells; Fig. 6 ). In addition, PEPCK mRNA levels in scrambled siRNA insulin-stimulated cells were significantly lower than those in GALNT2 siRNA insulin-stimulated cells (p b 0.05, Fig. 6 ). Thus, the observed deleterious effect of GALNT2 downregulation on ENPP1 expression is paralleled by a similar effect on downstream insulin signaling and action on glucose metabolism.
Role of GALNT2 upregulation on ENPP1 expression and on insulin signaling
Exposure of HepG2 cells to GALNT2 cDNA for 96 h, which almost doubled GALNT2 expression (Fig. 7, panel A) , reduced ENPP1 mRNA expression levels by 30% as compared to mock HepG2 control cells (p b 0.01, Fig. 7, panel B) , thus mirroring the data obtained by GALNT2 downregulation. In contrast, GALNT2 upregulation did not affect ENPP1 protein content as shown in Fig. 7 , panel C. This lack of effect is observed despite the maintained ability of transfected GALNT2 to bind ENPP1-3′UTR (Supplementary Fig. 2 ). Conversely, these apparently discordant results may be due to a high ENPP1 protein stability in HepG2 cells which makes it difficult to detect any effect of ENPP1 mRNA reduction due to GALNT2 overexpression. To test this hypothesis, we exposed cells to ENPP1 siRNA for 96 h and then measured both ENPP1 mRNA and protein content. While ENPP1 mRNA expression levels were decreased by 39 ± 12% as compared to scrambled siRNA HepG2 transfected cells (n = 3 experiments, Coherently with the unchanged ENPP1 protein content, insulininduced IR β-subunit autophosphorylation was similar in GALNT2 overexpression and mock HepG2 control cells (Fig. 8 panel B) . IR protein content was superimposable across all different experimental conditions ( Fig. 8 panel A) . Based upon these negative results no further experiments on downstream insulin signaling were carried out.
Discussion
Functional [4, 7, 10] metabolic [13, 14, 16] and genetic [18, 23, 25, [30] [31] [32] [33] [34] [35] [36] [37] [38] studies suggest that ENPP1 acts as a negative modulator of insulin signaling and action. Thus, addressing the mechanisms underlying ENPP1 expression may help unravel novel molecular mechanisms of insulin resistance.
Our study on human liver HepG2 cells shows that GALNT2 binds to ENPP1-3′UTR mRNA and inhibits ENPP1 transcript and protein levels. This finding adds to previous functional [24, 25] and genetic [23, 25] reports suggesting that, in fact, the 3′UTR is involved in the regulation of ENPP1 expression in human liver cells, the utmost target of insulin action on glucose homeostasis. Of note, a previously reported 3′UTR polymorphic haplotype did not impair GALNT2 binding affinity, thus suggesting that its effect on ENPP1 mRNA levels [25] is not mediated by GALNT2. Whether other SNPs associated with metabolic traits [23] which are located outside the most conserved 3′UTR we used for our experiments, affect GALNT2 binding may be interested to be addressed by further investigations. Also of note is that HSP70 was not identified as a binding protein of ENPP1-3′UTR, a finding which is in contrast with our previous reports [24] . We like to speculate that the different methods utilized in our present and previous studies (RNA-pull-down vs. RNA Mobility Shift Analysis) underline the different results we obtained.
A second important finding of this study is that GALNT2 downregulation affects insulin-induced IR β-subunit autophosphorylation, IRS-1 Tyr 895 and Akt Ser 473 phosphorylations and PEPCK expression, four key steps of insulin signaling and gluconeogenetic activity. These effects are very likely mediated, by ENPP1 protein up-regulation. In fact, GALNT2 overexpression, which down-regulates ENPP1 mRNA levels but not ENPP1 protein content, is not paralleled by any change of insulin-induced IR β-subunit autophosphorylation. This finding reinforces the hypothesis that ENPP1 up-regulation, mediates, at least partly, GALNT2 down-regulation effects on insulin signaling and action. We acknowledge that further experiments using cellular models lacking both ENPP1 alleles, are needed to definitively confirm such hypothesis. It is entirely possible that other mechanisms also underlie such GALNT2 effects. As a matter of fact, GalNAc-T2 coded by GALNT2 is responsible for the O-linked glycosylation, allowing the transfer of N-acetylgalactosamine from UDP-GalNAc to the hydroxyl group of a serine or threonine residue [29] . Such glycosylation has been reported to play an important role on insulin resistance and diabetes, either by competing for phosphorylation on insulin-stimulated sites on effector molecules, or by directly regulating components of insulin signaling, including IRS1 and Akt [39] [40] [41] [42] .
Regardless the mechanism of action, also data from the few studies so far published on GALNT2 expression levels in several models of metabolic abnormalities related to insulin resistance suggests that it modulates insulin resistance traits. While GALNT2 expression is reduced in liver of insulin resistant Goto-Kakizaki diabetic rats [43] , it is increased in adipose tissue of obese, insulin resistant non-diabetic PIMA Indians [44] . In addition, GALNT2 expression in mice causes an inverse modulation of serum HDL-c levels, an established marker of insulin sensitivity [45] . All in all, expression data in both humans and rodents, although somehow variable, clearly point to GALNT2 as a potential mediator of abnormalities related to insulin resistance. Further support to this hypothesis comes from studies showing that genetic variability at the GALNT2 locus (SNP rs4846914) is associated with decreased HDL-c and increased triglyceride levels [46] [47] [48] , two main components of the insulin resistance/metabolic syndrome.
Conclusions
In conclusion, our data identified GALNT2 as a new potential modulator of insulin signaling and action in human liver cells through the modulation of ENPP1 expression. Additional experiments in other cell types and tissues relevant to glucose metabolism are needed to confirm this finding, thus deeper addressing the role of GALNT2 as a potential target of novel treatments of insulin resistance and abnormal glucose homeostasis. Finally, because of the very restrictive prioritizing criteria we used to identify GALNT2, the list of ENPP1-3′UTR binding proteins may, in fact, contain additional important candidates to be investigated in further studies.
Supplementary data to this article can be found online at http:// dx.doi.org/10.1016/j.bbamcr.2013.02.032.
